T388 : Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases/24 cores
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
AJCC-TNM classification for mucosal melanoma of the head and neck
Clinical stage
Vulvovaginal mucosal melanoma Vulval melanomas are staged using the same AJCC-TNM classification as the table above. There is no staging system for vaginal melanoma, so a simplified clinical staging system can be used to categorise these melanomas. Vaginal melanoma
Anorectal mucosal melanoma Anorectal mucosal melanoma is staged using the same simplified staging system as vaginal melanoma. Anorectal mucosal melanoma
Primary tumor (T) * TX: Primary tumor cannot be assessed (e.g., shave biopsy or regressed melanoma) * T0: No evidence of primary tumor * Tis: Melanoma in situ * T1: Tumor 1.0 mm or less in thickness with or without ulceration * T1a: Tumor 1.0 mm or less in thickness and Clarks level II or III, no ulceration * T1b: Tumor 1.0 mm or less in thickness and Clarks level IV or V or with ulceration * T2: Tumor more than 1.0 mm but not more than 2.0 mm in thickness with or without ulceration * T2a: Tumor more than 1.0 mm but not more than 2.0 mm in thickness, no ulceration * T2b: Tumor more than 1.0 mm but not more than 2.0 mm in thickness, with ulceration * T3: Tumor more than 2.0 mm but not more than 4 mm in thickness with or without ulceration * T3a: Tumor more than 2.0 mm but not more than 4 mm in thickness, no ulceration * T3b: Tumor more than 2.0 mm but not more than 4 mm in thickness, with ulceration * T4: Tumor more than 4.0 mm in thickness with or without ulceration * T4a: Tumor more than 4.0 mm in thickness, no ulceration * T4b: Tumor more than 4.0 mm in thickness, with ulceration Regional lymph nodes (N) * NX: Regional lymph nodes cannot be assessed * N0: No regional lymph node metastasis * N1: Metastasis to 1 lymph node * N1a: Clinically occult (microscopic) metastasis * N1b: Clinically apparent (macroscopic) metastasis * N2: Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases * N2a: Clinically occult (microscopic) metastasis * N2b: Clinically apparent (macroscopic) metastasis * N2c: Satellite or in transit metastasis without nodal metastasis * N3: Metastasis in 4 or more regional nodes, or matted lymph nodes, or in transit metastasis or satellite(s) with metastatic regional node(s) Note: Micrometastases are diagnosed after elective or sentinel lymphadenectomy; macrometastases are defined as clinically detectable lymph nodes metastases confirmed by therapeutic lymphadenectomy, or when any lymph node metastasis exhibits gross extracapsular extension. Distant Metastasis (M) * MX: Distant metastasis cannot be assessed * M0: No distant metastasis * M1: Distant metastasis * M1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes * M1b: Metastasis to lung * M1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) Stage Groupings Stage 0 Tis, N0, M0 Stage IA T1a, N0, M0 Stage IB T1b, N0, M0 T2a, N0, M0 Stage IIA T2b, N0, M0 T3a, N0, M0 Stage IIB T3b, N0, M0 T4a, N0, M0 Stage IIC T4b, N0, M0 Stage III Any T, N1, M0 Any T, N2, M0 Any T, N3, M0 Stage IV Any T, any N, M1 Find overlapping cases with this tissue array:
|